US Stock MarketDetailed Quotes
ORGS Orgenesis
- 2.813
- +0.695+32.82%
15min DelayTrading Dec 26 12:06 ET
14.54MMarket Cap-0.11P/E (TTM)
3.500High2.000Low47.94KVolume2.180Open2.118Pre Close131.70KTurnover1.04%Turnover RatioLossP/E (Static)5.17MShares10.79952wk High-0.61P/B12.97MFloat Cap0.87052wk Low--Dividend TTM4.61MShs Float168.000Historical High--Div YieldTTM70.84%Amplitude0.870Historical Low2.747Avg Price1Lot Size
About Orgenesis Company
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Company Profile
SymbolORGS
Company NameOrgenesis
Listing DateMar 13, 2018
Founded2008
CEOMs. Vered Caplan
MarketPink Market
Employees146
Fiscal Year Ends12-31
Address20271 Goldenrod Lane
CityGermantown
ProvinceMaryland
CountryUnited States of America
Zip Code20876
Phone1-480-659-6404
Websitehttp://www.orgenesis.com
Company Executives
- Name
- Position
- Salary
- Vered Caplan
- Chairperson of the Board and Chief Executive Officer
- 341.38K
- Victor Miller
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- --
- Mark Goodman
- Director
- --
- Kevin Choquette
- Director
- --
- Ashish Nanda
- Independent Director
- 69.91K
- Dr. Itzhak Vider
- Independent Director
- --
- Yaron Adler
- Independent Director
- 64.64K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
